Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-041828

Chief Medical Officer sold 6,250 shares at an average $47.33 ($295,789)

  • Chief Medical Officer acquired 6,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BALDO LANCE Chief Medical Officer 2020-07-06 Option exercise +6,250 $7.80 $48,750 6,250 D: show line 1 in the form
BALDO LANCE Chief Medical Officer 2020-07-06 Sale −6,050 $47.29 $286,105 200 D: show line 2 in the form
BALDO LANCE Chief Medical Officer 2020-07-06 Sale −200 $48.42 $9,684 0 D: show line 3 in the form
Open-market sales · 6,250 sh · avg $47.33 · $295,789

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BALDO LANCE Chief Medical Officer 2020-07-06 Option exercise · Stock Option (Right to Buy) −6,250 437,500 D: show line 4 in the form
Loading xslF345X03/doc4.xml…